📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation (2019)

First Author: Miao L

Attributed to: E-TERM, Engineering Tissue Engineering and Regenerative Medicine funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41587-019-0247-3

PubMed Identifier: 31570898

Publication URI: http://europepmc.org/abstract/MED/31570898

Type: Journal Article/Review

Parent Publication: Nature Biotechnology

Issue: 10

ISSN: 1087-0156